Additional Flu Vaccines for the 21/22 Flu Season

Concepts

• influenza vaccines
• flu
• additional flu vaccines
• additional supply of influenza vaccine
• flu season
• sufficient supply of flu vaccine
• stock of flu vaccines
• combined effect of flu
• uptake of flu vaccines
• department of health

Location

United Kingdom: UK

Description

This Contract is for a centrally procured, additional supply of Influenza Vaccine to ensure sufficient supply of flu vaccine for the 21/22 flu season

Total Quantity or Scope

The Department of Health and Social Care is procuring a stock of flu vaccines over and above that which is needed for business as usual. This is in order to increase the uptake of flu vaccines for the 21/22 flu season while the covid-19 pandemic still persists and protect the population against the combined effect of flu and covid-19.

Award Detail

Award Criteria

CPV Codes

• 33651660 - Influenza vaccines

Legal Justification

The Authority needed to secure additional flu vaccines to supplement business as usual stocks so that it was in a position of being ready to co-administer the Covid-19 booster and flu vaccine simultaneously as this will result in a greater uptake of the flu vaccine to a wider cohort of the population. However the high global demand for flu vaccines and the limited global stocks of these vaccinations gave rise to an extremely urgent need for the Authority to purchase additional flu vaccines for the 2021/22 flu season to maintain security of supply to immunise the population as required and safeguard public health. It was imperative in the face of high global demand, that the Authority moved quickly to secure supply and as such there was insufficient time to comply with the standard Open Procedure time scales for this procurement. Accordingly, the Authority used the negotiated procedure without prior publication – Regulation 32(2)(c) – Extreme Urgency Route (i.e. direct award) permitted under the Public Contract Regulations 2015 (as amended) to conduct this procurement

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This Contract is for a centrally procured, additional supply of vaccine from 3 suppliers: 1. Flucelvax TetraQuadrivalent Influenza Vaccine from Seqirus UK Limited at a value of £7,455,000 2. Influvac Tetra QIVe Influenza Vaccine from Viatris UK Healthcare at a value of £10,000,000 3. Supemtek Quadrivalent Influenza Vaccine from Aventis Pharma Ltd T/A Sanofi at a value of £14,110,000; to ensure sufficient supply of flu vaccine for the 21/22flu season